GeneDx Holdings Current Ratio 2020-2024 | WGS
GeneDx Holdings current ratio from 2020 to 2024. Current ratio can be defined as a liquidity ratio that measures a company's ability to pay short-term obligations.
| GeneDx Holdings Current Ratio Historical Data | |||
|---|---|---|---|
| Date | Current Assets | Current Liabilities | Current Ratio |
| 2024-09-30 | $0.19B | $0.08B | 2.41 |
| 2024-06-30 | $0.16B | $0.07B | 2.38 |
| 2024-03-31 | $0.16B | $0.05B | 3.22 |
| 2023-12-31 | $0.18B | $0.06B | 3.10 |
| 2023-09-30 | $0.17B | $0.07B | 2.51 |
| 2023-06-30 | $0.21B | $0.08B | 2.53 |
| 2023-03-31 | $0.27B | $0.12B | 2.29 |
| 2022-12-31 | $0.21B | $0.14B | 1.47 |
| 2022-09-30 | $0.31B | $0.16B | 1.89 |
| 2022-06-30 | $0.40B | $0.21B | 1.97 |
| 2022-03-31 | $0.41B | $0.10B | 4.08 |
| 2021-12-31 | $0.48B | $0.10B | 4.77 |
| 2021-09-30 | $0.54B | $0.07B | 7.55 |
| 2021-06-30 | $0.00B | $0.00B | 0.18 |
| 2021-03-31 | $0.00B | $0.00B | 0.62 |
| 2020-12-31 | $0.00B | 0.00 | |
| 2020-09-30 | $0.00B | 0.00 | |
| 2019-12-31 | $0.00B | 0.00 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $2.126B | $0.203B |
| GeneDx Holdings Corp. is at the forefront of transforming healthcare through its industry-leading exome and genome testing and interpretation, fueled by rare disease data sets. GeneDx Holdings Corp., formerly known as Sema4 Holdings Corp., is based in STAMFORD, Conn. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Elevance Health (ELV) | United States | $86.493B | 10.73 |
| Cencora (COR) | United States | $43.979B | 16.54 |
| DiDi Global (DIDIY) | China | $22.358B | 0.00 |
| Natera (NTRA) | United States | $21.439B | 0.00 |
| ICON (ICLR) | Ireland | $17.593B | 15.67 |
| Viatris (VTRS) | United States | $14.801B | 4.56 |
| Avantor (AVTR) | United States | $14.538B | 21.80 |
| Revvity (RVTY) | United States | $13.672B | 23.75 |
| BioMerieux (BMXMF) | France | $12.468B | 0.00 |
| CochLear (CHEOY) | Australia | $12.010B | 0.00 |
| Solventum (SOLV) | United States | $11.499B | 0.00 |
| Doximity (DOCS) | United States | $10.879B | 64.03 |
| Medpace Holdings (MEDP) | United States | $10.651B | 30.01 |
| Charles River Laboratories (CRL) | United States | $9.526B | 18.41 |
| HealthEquity (HQY) | United States | $8.292B | 41.60 |
| Sonic Healthcare (SKHHY) | Australia | $8.215B | 0.00 |
| Bausch + Lomb (BLCO) | Canada | $6.290B | 29.28 |
| Amplifon S.p.A (AMFPF) | Italy | $5.864B | 29.89 |
| Sotera Health (SHC) | United States | $3.838B | 20.53 |
| Organon (OGN) | United States | $3.794B | 3.83 |
| BrightSpring Health Services (BTSG) | United States | $3.037B | 64.59 |
| Surgery Partners (SGRY) | United States | $2.671B | 30.45 |
| Concentras Parent (CON) | United States | $2.608B | 0.00 |
| Ardent Health Partners (ARDT) | United States | $2.294B | 0.00 |
| Premier (PINC) | United States | $2.067B | 10.76 |
| Alignment Healthcare (ALHC) | United States | $2.055B | 0.00 |
| PACS (PACS) | United States | $1.995B | 0.00 |
| GoodRx Holdings (GDRX) | United States | $1.711B | 44.90 |
| Ryman Healthcare (RYHTY) | New Zealand | $1.651B | 0.00 |
| Teladoc Health (TDOC) | United States | $1.594B | 0.00 |
| Establishment Labs Holdings (ESTA) | $1.246B | 0.00 | |
| Progyny (PGNY) | United States | $1.237B | 25.05 |
| Embecta (EMBC) | United States | $1.179B | 8.24 |
| Pediatrix Medical (MD) | United States | $1.177B | 11.52 |
| CareDx (CDNA) | United States | $1.149B | 0.00 |
| AMN Healthcare Services Inc (AMN) | United States | $0.891B | 6.03 |
| QDM (QDMI) | Hong Kong, SAR China | $0.790B | 20.69 |
| Agilon Health (AGL) | United States | $0.787B | 0.00 |
| SBC Medicals (SBC) | United States | $0.553B | 0.00 |
| InnovAge Holding (INNV) | United States | $0.550B | 0.00 |
| Auna S.A (AUNA) | Luxembourg | $0.509B | 0.00 |
| Sonida Senior Living (SNDA) | United States | $0.444B | 0.00 |
| DocGo (DCGO) | United States | $0.431B | 16.23 |
| Enhabit (EHAB) | United States | $0.385B | 33.30 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.276B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.268B | 0.00 |
| LifeMD (LFMD) | United States | $0.213B | 0.00 |
| Biodesix (BDSX) | United States | $0.212B | 0.00 |
| MultiPlan (MPLN) | United States | $0.198B | 0.00 |
| Beauty Health (SKIN) | United States | $0.185B | 0.00 |
| Nutex Health (NUTX) | United States | $0.173B | 0.00 |
| ModivCare (MODV) | United States | $0.163B | 8.83 |
| So-Young (SY) | China | $0.093B | 15.80 |
| Ascend Wellness Holdings (AAWH) | United States | $0.081B | 0.00 |
| NeueHealth (NEUE) | United States | $0.062B | 1.65 |
| IceCure Medical (ICCM) | Israel | $0.051B | 0.00 |
| Singular Genomics Systems (OMIC) | United States | $0.049B | 0.00 |
| OncoCyte (OCX) | United States | $0.036B | 0.00 |
| Pheton Holdings (PTHL) | China | $0.025B | 0.00 |
| Co-Diagnostics (CODX) | United States | $0.025B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.024B | 0.00 |
| Oncology Institute (TOI) | United States | $0.017B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.009B | 0.00 |
| XWELL (XWEL) | United States | $0.008B | 0.00 |
| KindlyMD (KDLY) | United States | $0.006B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.006B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.004B | 0.00 | |
| NewGenIvf Group (NIVF) | Thailand | $0.003B | 0.00 |
| ISpecimen (ISPC) | United States | $0.003B | 0.00 |
| Aclarion (ACON) | United States | $0.001B | 0.00 |
| Cano Health (CANOQ) | United States | $0.001B | 0.00 |